NCT00963521 Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission Status COMPLETED Phase PHASE1
NCT00963274 Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE1
NCT00955916 CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE2
NCT00952237 Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF Status COMPLETED Phase PHASE1
NCT00952185 Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers Status TERMINATED Phase NA
NCT00949117 Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer Status TERMINATED Phase PHASE2
NCT00948064 Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00946283 Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome Status TERMINATED Phase NA
NCT00945815 S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00943943 Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations Status COMPLETED Phase PHASE1
NCT00943800 Combined Haploidentical-Cord Blood Transplantation for Adults and Children Status COMPLETED Phase NA
NCT00943709 Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia Status WITHDRAWN Phase PHASE3
NCT00943592 Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00943319 Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00941928 Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE2